Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Virology
|
January 15, 2003
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2
RosaMaria Roccasecca, Helenia Ansuini, Alessandra Vitelli, et al.
The Science of the Total Environment
|
October 22, 2022
Study of antibiotic resistance in freshwater ecosystems with low anthropogenic impact
Anna Navarro, Isabella Sanseverino, Francesca Cappelli, et al.
Cancers
|
February 13, 2026
Targeting Colorectal Cancer Stem Cells Through Inhibition of the Fibroblast Growth Factor Receptor 4 Pathway with a Novel Antibody
Gessica Filocamo, Mariachiara Buccarelli, Armin Lahm, et al.
Nature Medicine
|
February 8, 2006
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
Antonella Folgori, Stefania Capone, Lionello Ruggeri, et al.
Vaccines
|
August 28, 2021
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction
Guido Leoni, Anna Morena D'Alise, Fabio Giovanni Tucci, et al.
BMC Genomics
|
March 31, 2009
Comparative expression pathway analysis of human and canine mammary tumors
Paolo Uva, Luigi Aurisicchio, James Watters, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies
Olaf Kinzel, Daniela Fattori, Ester Muraglia, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide
Philippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion
Anna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications
|
June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Virology
|
January 15, 2003
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2
RosaMaria Roccasecca, Helenia Ansuini, Alessandra Vitelli, et al.
The Science of the Total Environment
|
October 22, 2022
Study of antibiotic resistance in freshwater ecosystems with low anthropogenic impact
Anna Navarro, Isabella Sanseverino, Francesca Cappelli, et al.
Cancers
|
February 13, 2026
Targeting Colorectal Cancer Stem Cells Through Inhibition of the Fibroblast Growth Factor Receptor 4 Pathway with a Novel Antibody
Gessica Filocamo, Mariachiara Buccarelli, Armin Lahm, et al.
Nature Medicine
|
February 8, 2006
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
Antonella Folgori, Stefania Capone, Lionello Ruggeri, et al.
Vaccines
|
August 28, 2021
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction
Guido Leoni, Anna Morena D'Alise, Fabio Giovanni Tucci, et al.
BMC Genomics
|
March 31, 2009
Comparative expression pathway analysis of human and canine mammary tumors
Paolo Uva, Luigi Aurisicchio, James Watters, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies
Olaf Kinzel, Daniela Fattori, Ester Muraglia, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide
Philippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion
Anna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications
|
June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Page
of 4